.png){kind=small}
Amit is an associate in the firm’s Commercial Law department.
Amit’s practice includes, among others, ongoing legal advice to companies and support of investment and financing rounds.
Among other things, Amit engages in preparing commercial agreements such as NDAs, service agreements, founder and shareholder agreements, purchase agreements and employment agreements.
Israel, 2020
(LL.B), Bar-Ilan University, 2018
Hebrew, English
Congratulations to Guesty on their remarkable achievement of securing a $130M financing round, spearheaded by KKR, alongside Apax Digital, Inovia Capital, MSD Partners, and Sixth Street.
At EBN, we are privileged to have been a part of this journey.
Thank you to our excellent legal team: Roy Caner, Jonathan Achiron, Amit Horovitz, Yosef Mark, Ori Zahav, Rachel Grin, and our intern Tamar Lia Toledano.
We also want to thank Lior Etgar and Danit Yehezkel for their contribution to navigating the complexities of privacy law.
We look forward to continued collaboration and witnessing the success of Guesty.
To read more, click here.
Congratulation to our client Hetz Ventures on leading the $5M seed round in Prompt Security, with the participation of Four Rivers, CyberFuture and private investors.
Great working with Pavel Livshiz and Anat Eitan (Zach).
Thanks to the team, Roy Caner, Yael Benyayer and senior associate Amit Horovitz.
To read more, click here.
Exciting News from Anecdotes!
Congratulations to our client anecdotes and its rockstar founders Yair Kuznitsov and Roi Amior for the succesful $25M round led by Glilot Capital Partners with the participation of Red Dot Capital Partners, Vintage Investment Partners, Shasta Ventures and new investors Vertex Ventures Israel and DTCP! Welcome aboard.
Greatful to work with the amazing EBN team that includes Roy Caner, Viva Gayer, Amit Horovitz, Ori Zahav, Yarden Dover and in Privacy, Lior Etgar.
Click here, to read more.
Proud to have represented our client, Permira Growth, in an acquisition, through a secondary transaction, of shares in BioCatch Ltd.
This was the first-ever investment of the Permira Growth fund in an Israeli company.
BioCatch develops a product for the financial markets that verifies identities through behavioral biometrics using artificial intelligence.
Permira was represented by Partners Doni Toledano and Roy Caner, and Associate Amit Horovitz, of our Corporate, Hi-Tech and M&A Department, Partners Dr. Eran Lampert and Tal Alon of our Tax Department, and intern Yarden Dover.
We were happy to represent our client, ,Debiopharm Innovation Fund, in leading a USD 6 million Series Seed financing round in YonaLink Ltd.
YonaLink Ltd. develops a SaaS Platform that is providing missing link in clinical trial data collection, securely automating real-time transfer of up-to-date patient data directly from EHRs to EDC systems and brings new levels of speed, quality and efficiency to clinical trial data collection and validation across the globe and therapeutic areas.
Debiopharm Innovation Fund was represented by partner Roy Caner, associate Amit Horovitz and intern Elad Amir from our Hi-Tech, Corporate and M&A Department, Partner Eyal Birenberg, LL.M., LL.B. Birenberg and Associate Bar Artzy of our Labor Department and Partner Lior Etgar and Associate Amir Noy of our Privacy Practice.
We are delighted to have represented Guesty in a series of acquisitions that included (i) the acquisition of assets from Kigo Inc., a US company, which included the purchase of the entire share capital of Kigo Rental Systems SL., its Spanish subsidiary; (ii) the acquisition of HiRUM (Australasia) Pty Ltd. and HiRUM Intellectual Pty Ltd., Australian companies; and (iii), in the acquisition of YieldPlanet S.A., a Polish company.
Guesty has developed an automated property management system for all stages of renting and hosting on a variety of online platforms.
Guesty was represented by partners Roy Caner and Jonathan Achiron, associates Shmarya Green, Amit Horovitz, Yonatan Levy, Amir Noy, and intern Ariella Mankowitz, all of EBN ‘s Mergers and Acquisitions and hi-tech department, as well as Lior Etgar, partner in EBN’s Privacy group.
Proud to have represented our client Guesty in its USD 170 million Series E financing round, co-led by Apax Digital Funds, MSD Partners, and Sixth Street Growth, together with existing investors including Viola Growth and Flashpoint.
Guesty has developed a property management platform for short term rentals and has become a global leader in the hospitality industry, with clients in over 80 countries.
Guesty was represented by partners Roy Caner and Jonathan Achiron, associates Shmarya Green and Amit Horovitz, and interns Stav Levy and Ariella Mankowitz from our Hi-Tech, Corporate and M&A Department with the assistance of Eyal Birenberg on labor issues and Lior Etgar on Privacy.
To read the article in Globes, click here.
UroGen Pharma LTD., on signing a $ 100 million term loan financing facility with funds managed by Pharmakon Advisors, L.P.
UroGen Pharma Ltd. (Nasdaq: URGN) a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers.
UroGen Pharma LTD. Was represented by Partner Yaron Sobol, Senior associate Ben Frenkel and Associate Amit Horovitz from our Corporate and M&A Department.
Click on the first comment to read the full article on Yahoo >>
Vertex Ventures, Debiopharm, Grove Ventures and Fosun RZ Capital, participated in the USD 33 million Round B investment in Nucleai, an AI-powered spatial biology company, which seeks to transform drug development and clinical treatment decisions through pathology data.
Vertex Ventures, Debiopharm, Grove Ventures and Fosun RZ Capital were represented by Partner Roy Caner and associate Amit Horovitz from Corporate, Hi-Tech, and M&A Department.
To read the full article in hebrew, click on Calcalist.
